Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
- NCT03040999
- 3475-412, 2016-003934-25, MK-3475-412, 173640
Trial sponsor
Merck
Scientific Title
A Randomized Phase III Study of Pembrolizumab Given Concomitantly With Chemoradiation and as Maintenance Therapy Versus Chemoradiation Alone in Subjects With Locally Advanced Head and Neck Squamous Cell Carcinoma